XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Changes in Convertible Preferred Stock and Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Convertible Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive (Loss) Income
Retained Earnings
Beginning balance (in shares) at Dec. 31, 2020   112,878        
Beginning balance at Dec. 31, 2020   $ 562,467        
Ending balance (in shares) at Sep. 30, 2021   0        
Ending balance at Sep. 30, 2021   $ 0        
Beginning balance (in shares) at Dec. 31, 2020     73,108      
Beginning balance at Dec. 31, 2020 $ 963,584   $ 0 $ 231,024 $ 6,256 $ 726,304
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options, net of repurchases (in shares)     22,257      
Issuance of common stock upon exercise of stock options, net of repurchases 181,025     181,025    
Stock-based compensation expense 559,652     559,652    
Issuance of equity instruments as consideration for business combination (in shares)     3,891      
Issuance of equity instruments as consideration for business combinations 509,379     509,379    
Conversion of preferred stock (in shares)   (112,878) (112,878)      
Conversion of preferred stock 562,467 $ (562,467) $ 2 562,465    
Issuance of common stock from exercise of warrants (in shares)     412      
Issuance of shares from exercise of warrants 433     433    
Issuance of common stock upon settlement of RSUs and restricted common stock, net of shares withheld (in shares)     1,116      
Issuance of common stock upon settlement of RSUs and restricted common stock, net of shares withheld (103,136)     (103,136)    
Purchase of capped calls (90,131)     (90,131)    
Comprehensive loss (6,688)       (6,688)  
Net (loss) income 2,783,912         2,783,912
Ending balance (in shares) at Sep. 30, 2021     213,662      
Ending balance at Sep. 30, 2021 5,360,497   $ 2 1,850,711 (432) 3,510,216
Beginning balance (in shares) at Jun. 30, 2021   0        
Beginning balance at Jun. 30, 2021   $ 0        
Ending balance (in shares) at Sep. 30, 2021   0        
Ending balance at Sep. 30, 2021   $ 0        
Beginning balance (in shares) at Jun. 30, 2021     209,876      
Beginning balance at Jun. 30, 2021 4,623,425   $ 2 1,516,533 2,774 3,104,116
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options, net of repurchases (in shares)     2,964      
Issuance of common stock upon exercise of stock options, net of repurchases 43,221     43,221    
Stock-based compensation expense 264,941     264,941    
Issuance of equity instruments as consideration for business combination (in shares)     211      
Issuance of equity instruments as consideration for business combinations 77,482     77,482    
Issuance of common stock upon settlement of RSUs and restricted common stock, net of shares withheld (in shares)     611      
Issuance of common stock upon settlement of RSUs and restricted common stock, net of shares withheld (51,466)     (51,466)    
Comprehensive loss (3,206)       (3,206)  
Net (loss) income 406,100         406,100
Ending balance (in shares) at Sep. 30, 2021     213,662      
Ending balance at Sep. 30, 2021 5,360,497   $ 2 1,850,711 (432) 3,510,216
Beginning balance (in shares) at Dec. 31, 2021   0        
Beginning balance at Dec. 31, 2021   $ 0        
Ending balance (in shares) at Sep. 30, 2022   0        
Ending balance at Sep. 30, 2022   $ 0        
Beginning balance (in shares) at Dec. 31, 2021     217,117      
Beginning balance at Dec. 31, 2021 $ 6,381,689   $ 2 2,034,658 (3,395) 4,350,424
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options, net of repurchases (in shares) 3,012   3,052      
Issuance of common stock upon exercise of stock options, net of repurchases $ 45,260     45,260    
Stock-based compensation expense 1,232,815     1,232,815    
Issuance of equity instruments as consideration for business combination (in shares)     1,663      
Issuance of equity instruments as consideration for business combinations 314,356     314,356    
Issuance of common stock upon settlement of RSUs and restricted common stock, net of shares withheld (in shares)     4,618      
Issuance of common stock upon settlement of RSUs and restricted common stock, net of shares withheld (268,746)     (268,746)    
Issuance of common stock under the Employee Stock Purchase Plan (shares)     155      
Issuance of common stock under the Employee Stock Purchase Plan 14,863     14,863    
Other 7,124     7,124    
Comprehensive loss (33,098)       (33,098)  
Net (loss) income (2,067,948)         (2,067,948)
Ending balance (in shares) at Sep. 30, 2022     226,605      
Ending balance at Sep. 30, 2022 5,626,315   $ 2 3,380,330 (36,493) 2,282,476
Beginning balance (in shares) at Jun. 30, 2022   0        
Beginning balance at Jun. 30, 2022   $ 0        
Ending balance (in shares) at Sep. 30, 2022   0        
Ending balance at Sep. 30, 2022   $ 0        
Beginning balance (in shares) at Jun. 30, 2022     224,398      
Beginning balance at Jun. 30, 2022 5,813,389   $ 2 3,004,459 (18,183) 2,827,111
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options, net of repurchases (in shares)     812      
Issuance of common stock upon exercise of stock options, net of repurchases 10,318     10,318    
Stock-based compensation expense 417,721     417,721    
Issuance of common stock upon settlement of RSUs and restricted common stock, net of shares withheld (in shares)     1,395      
Issuance of common stock upon settlement of RSUs and restricted common stock, net of shares withheld (55,613)     (55,613)    
Other 3,445     3,445    
Comprehensive loss (18,310)       (18,310)  
Net (loss) income (544,635)         (544,635)
Ending balance (in shares) at Sep. 30, 2022     226,605      
Ending balance at Sep. 30, 2022 $ 5,626,315   $ 2 $ 3,380,330 $ (36,493) $ 2,282,476